Janus Henderson Group’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $357K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $9.22M | Sell |
|
|||||
|
2022
Q1 | $27.2M | Buy |
|
|||||
|
2021
Q4 | $36.2M | Sell |
|
|||||
|
2021
Q3 | $62.5M | Sell |
|
|||||
|
2021
Q2 | $66.1M | Sell |
|
|||||
|
2021
Q1 | $73.4M | Buy |
|
|||||
|
2020
Q4 | $64.4M | Buy |
|
|||||
|
2020
Q3 | $57.5M | Sell |
|
|||||
|
2020
Q2 | $52M | Sell |
|
|||||
|
2020
Q1 | $42.2M | Buy |
|
|||||
|
2019
Q4 | $43.6M | Buy |
|